Author

Bing Guan

Observed name: Guan, Bing

Institution: Suzhou University

Observed institution: Suzhou University

ORCID: 0000-0003-2206-6759

Observed ORCID: 0000-0003-2206-6759

OpenAlex ID: A5138268551

PD-1/PD-L1 inhibitors combined with chemotherapy or as monotherapy versus chemotherapy alone or observation in triple-negative breast cancer: a systematic review and updated meta-analysis incorporating long-term survival data

2026 · Bing Guan, Yawen Chen, et al. · Frontiers in Immunology

Oral selective estrogen receptor degraders in ER+/HER2− breast cancer: a systematic review with pooled analysis of metastatic randomized trials and narrative synthesis of adjuvant evidence

2026 · Bing Guan, Sijia Zhang, et al. · Frontiers in Oncology

Prototype contrastive alignment with clinical attention enables multi-modal breast cancer molecular subtyping

2026 · Bing Guan, Rong Zhou, et al. · Scientific Reports

ProtoCA: Prototype-based Contrastive Alignment for Multi-modal Breast Cancer Subtype Classification under Extreme Data Imbalance

2026 · Guan, Bing · Zenodo (CERN European Organization for Nuclear Research)

`FIS1_ARCosome_TNBC_Code_Data`

2026 · Guan, Bing · Zenodo (CERN European Organization for Nuclear Research)

XRCC3_DeltaExon7_Computational_Analysis

2026 · Guan, Bing · Zenodo (CERN European Organization for Nuclear Research)

Works count: 6

Citation count:

H-index:

I10-index: